Clinical trial · Observational
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
A Prospective Randomized Trial on the Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology
NCT02727673CI-TRIAL-00021612completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Stem Cells | — | UNRESOLVED | — |
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Postoperative Recurrence and Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- healthy volunteers
- description
- matched group
- label
- hepatitis cirrhosis
- description
- negative group
- label
- hepatocellular carcinoma
- description
- patients with primary HCC
Primary outcomes (1)
- measure
- the overall survival rate of each group
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male or female patients \> 18 years and \<=70 years of age; 2. No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal. 3. Patients who can understand this trial and have signed information consent Exclusion Criteria: 1. Reject to attend； 2. Impossible to come to our hospital for physical examination regularly; 3. Patients with other diseases which may affect the treatment mentioned
References
Publications (0)
Data not yet available
No reference posted for this study.